drugset
drugset / Trial / NCT04312880

Tranexamic Acid Infusion During Elective Spine Surgery

NCT04312880 ↗

Phase 4 Enrolling by invitation 65 enrolled Albany Medical College
RandomizedParallel-groupSingle-blindTreatment

Summary

Tranexamic acid (TXA) is an agent that has been shown to be safe and effective to reduce blood loss in surgical procedures. The purpose of the study is to assess the effect of transexamic on elective decompressive lumbar spine surgery with and without fusion.

Timeline

Start
2018-12-01
Primary completion
2021-01-01
Completion
2021-01-01

Drugs

EvaluationDrugModalityDoseRoute
Subject Tranexamic Acid Small molecule — Intravenous

Indications

No indication recorded.